Press-release for stocks related to patent for BIO

Prices are updated after-hours

Bio-Rad and QIAGEN announce patent settlement and cross-licensing agreement
Published: 2023-07-26 (Crawled : 20:00) - globenewswire.com
QGEN | $40.0 1.34% 0.0% 1.1M

| -15.33% | O: 0.76% H: 0.21% C: -1.87%
BIO | $279.73 -0.46% 0.0% 290K

| -33.81% | O: 0.56% H: 1.6% C: -0.67%
QGEN | $40.0 1.34% 0.0% 1.1M

| -15.33% | O: 0.76% H: 0.21% C: -1.87%
patent agreement

10x Genomics Signs Global Patent Cross License Agreement with Bio-Rad
Published: 2021-07-27 (Crawled : 11:00) - globenewswire.com
BIO | $279.73 -0.46% 0.0% 290K

| -59.2% | O: 0.17% H: 2.49% C: 2.34%
TXG | $27.92 -3.56% -3.69% 2M

| -84.44% | O: -0.19% H: 0.64% C: 0.3%
genomic patent license

67%

33%

Save your searches and get alerts when important news are released.